85 related articles for article (PubMed ID: 2692145)
1. [How long should antithrombotic therapy be continued following aortocoronary bypass surgery?].
Pfisterer M; Jockers G; Regenass S; Schmitt HE; Grädel E; Burkart F
Schweiz Med Wochenschr; 1989 Oct; 119(43):1518-20. PubMed ID: 2692145
[TBL] [Abstract][Full Text] [Related]
2. Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations.
Chesebro JH; Fuster V; Elveback LR; Clements IP; Smith HC; Holmes DR; Bardsley WT; Pluth JR; Wallace RB; Puga FJ
N Engl J Med; 1984 Jan; 310(4):209-14. PubMed ID: 6361561
[TBL] [Abstract][Full Text] [Related]
3. [Improved flow through aortocoronary venous bypasses after anticoagulant therapy. A prospective randomized study].
Gohlke H; Gohlke-Bärwolf C; Stürzenhofecker P; Görnandt L; Ritter B; Reichelt M; Buchwalsky R; Schmuziger M; Roskamm H
Schweiz Med Wochenschr; 1981 Nov; 111(45):1722-4. PubMed ID: 6975997
[TBL] [Abstract][Full Text] [Related]
4. The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency.
Sharma GV; Khuri SF; Josa M; Folland ED; Parisi AF
Circulation; 1983 Sep; 68(3 Pt 2):II218-21. PubMed ID: 6347428
[TBL] [Abstract][Full Text] [Related]
5. Acetylsalicylic acid and dipyridamole improve the early patency of aorta-coronary bypass grafts. A double-blind, placebo-controlled, randomized trial.
Rajah SM; Salter MC; Donaldson DR; Subba Rao R; Boyle RM; Partridge JB; Watson DA
J Thorac Cardiovasc Surg; 1985 Sep; 90(3):373-7. PubMed ID: 3897722
[TBL] [Abstract][Full Text] [Related]
6. The effect of antithrombotic therapy on patency rates of saphenous vein coronary artery bypass grafts.
McEnany MT; Salzman EW; Mundth ED; DeSanctis RW; Harthorne JW; Weintraub RM; Gates S; Austen WG
J Thorac Cardiovasc Surg; 1982 Jan; 83(1):81-9. PubMed ID: 7033673
[TBL] [Abstract][Full Text] [Related]
7. [Permeability of aortocoronary bypass after 6 months. A multicenter French study].
Ollivier JP
Arch Mal Coeur Vaiss; 1991 Apr; 84(4):537-42. PubMed ID: 2064515
[TBL] [Abstract][Full Text] [Related]
8. Trial of low-dose aspirin plus dipyridamole versus anticoagulants for prevention of aortocoronary vein graft occlusion.
Pfisterer M; Burkart F; Jockers G; Meyer B; Regenass S; Burckhardt D; Schmitt HE; Müller-Brand J; Skarvan K; Stulz P
Lancet; 1989 Jul; 2(8653):1-7. PubMed ID: 2567792
[TBL] [Abstract][Full Text] [Related]
9. Placebo-controlled trial of enteric coated aspirin in coronary bypass graft patients. Effect on graft patency.
Hockings BE; Ireland MA; Gotch-Martin KF; Taylor RR
Med J Aust; 1993 Sep; 159(6):376-8. PubMed ID: 8377686
[TBL] [Abstract][Full Text] [Related]
10. Failure of antiplatelet and anticoagulant therapy to improve patency of grafts after coronary-artery bypass: a controlled, randomized study.
Pantely GA; Goodnight SH; Rahimtoola SH; Harlan BJ; DeMots H; Calvin L; Rösch J
N Engl J Med; 1979 Nov; 301(18):962-6. PubMed ID: 386118
[TBL] [Abstract][Full Text] [Related]
11. Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands.
van der Meer J; Hillege HL; Kootstra GJ; Ascoop CA; Mulder BJ; Pfisterer M; van Gilst WH; Lie KI
Lancet; 1993 Jul; 342(8866):257-64. PubMed ID: 8101300
[TBL] [Abstract][Full Text] [Related]
12. A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency.
Chesebro JH; Clements IP; Fuster V; Elveback LR; Smith HC; Bardsley WT; Frye RL; Holmes DR; Vlietstra RE; Pluth JR; Wallace RB; Puga FJ; Orszulak TA; Piehler JM; Schaff HV; Danielson GK
N Engl J Med; 1982 Jul; 307(2):73-8. PubMed ID: 7045659
[TBL] [Abstract][Full Text] [Related]
13. [Dipyridamole and low-dose aspirin in patients with aortocoronary bypass--comparison with anticoagulation].
Pfisterer M; Jockers G; Burkart F; Schmitt HE; Wolff G; Skarvan K; Stulz P; Hasse J; Grädel E
Schweiz Med Wochenschr; 1987 Oct; 117(43):1688-92. PubMed ID: 3501162
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis and prevention of aortocoronary bypass graft occlusion.
Chesebro JH; Fuster V
Int J Clin Pharmacol Res; 1986; 6(4):261-7. PubMed ID: 3531036
[TBL] [Abstract][Full Text] [Related]
15. [The effect of indobufen on aortocoronary bypass patency after 1 week and after 1 year].
Rohn V; Pirk J; Mach T
Cor Vasa; 1993; 35(4):162-4. PubMed ID: 8403942
[TBL] [Abstract][Full Text] [Related]
16. Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon Study.
van der Meer J; Brutel de la Rivière A; van Gilst WH; Hillege HL; Pfisterer M; Kootstra GJ; Dunselman PH; Mulder BJ; Lie KI
J Am Coll Cardiol; 1994 Nov; 24(5):1181-8. PubMed ID: 7930237
[TBL] [Abstract][Full Text] [Related]
17. Effect of aspirin and dipyridamole on the patency of lower extremity bypass grafts.
Kohler TR; Kaufman JL; Kacoyanis G; Clowes A; Donaldson MC; Kelly E; Skillman J; Couch NP; Whittemore AD; Mannick JA
Surgery; 1984 Sep; 96(3):462-6. PubMed ID: 6474351
[TBL] [Abstract][Full Text] [Related]
18. Effect of various antithrombotic regimens (aspirin, aspirin plus dipyridamole, anticoagulants) on the functional status of patients and grafts one year after coronary artery bypass grafting.
Mulder BJ; van der Doef RM; van der Wall EE; Tijssen JG; Piek JJ; van der Meer J; Dunning AJ
Eur Heart J; 1994 Aug; 15(8):1129-34. PubMed ID: 7988607
[TBL] [Abstract][Full Text] [Related]
19. Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent.
Zimmermann N; Gams E; Hohlfeld T
Eur J Cardiothorac Surg; 2008 Jul; 34(1):93-108. PubMed ID: 18448350
[TBL] [Abstract][Full Text] [Related]
20. Prevention of aortocoronary vein bypass graft occlusion: which antithrombotic treatment and for how long?
Pfisterer M; Burkart F; Jockers G; Meyer B; Regenass S; Burckhardt D; Schmitt HE; Müller-Brand J; Skarvan K; Stulz P
Thromb Res Suppl; 1990; 12():11-21. PubMed ID: 2082483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
